Thanks Davie. Why is there talk about the results in April resulting in a potential bid by BMS if VLA are only presenting trial results with Keytruda??
Is it because there is a belief that any trials involving Yevroy will be sub optimal and Cavatak will he swooped upon by BMS to boosy resultsy?
- Forums
- ASX - By Stock
- VLA
- 63 Million Shares traded since announcement
63 Million Shares traded since announcement, page-7
-
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online